Optiver Holding
OCUL icon

Optiver Holding’s Ocular Therapeutix OCUL Stock Holding History

Optiver Holding’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85 Sell
10
-563
-98% -$5.37K ﹤0.01% 2246
2025
Q4 		$6.96K Sell
573
-404
-41% -$4.91K ﹤0.01% 1236
2025
Q3 		$11.4K Buy
977
+132
+16% +$1.58K ﹤0.01% 1215
2025
Q2 		$7.84K Hold
845
– – ﹤0.01% 1073
2025
Q1 		$6.19K Hold
845
– – ﹤0.01% 1037
2024
Q4 		$7.22K Buy
845
+805
+2,013% +$7.85K ﹤0.01% 808
2024
Q3 		$348 Sell
40
-1,285
-97% -$10.6K ﹤0.01% 923
2024
Q2 		$9.06K Buy
+1,325
New +$8.18K ﹤0.01% 730

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return